SCHEMBL1978098

SCHEMBL1978098

O=COCCC1CCOCC1

nearest known ligand 0.33

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
DAO P14920 1/20 0.33
NAAA Q02083 1/20 0.33
CHRM2 P08172 1/20 0.31
CHRM1 P11229 1/20 0.31
CHRM3 P20309 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28326646 0.88 NAAA (0.37) DAONAAA
SCHEMBL28326636 0.86 NAAA (0.42) DAONAAA
SCHEMBL456220 0.84
SCHEMBL1666337 0.80 ADH1B (0.37)
SCHEMBL1451000 0.80
SCHEMBL15304489 0.79 DAO (0.30) DAONAAA
SCHEMBL28806594 0.79
SCHEMBL1861051 0.78 MAOB (0.30)
SCHEMBL5543967 0.78 ADH1B (0.40)
SCHEMBL27705383 0.78 ADH1B (0.40)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 65 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115572252-A Isoindolinone inhibitors of MDM2-P53 interaction with anti-cancer activity 阿斯泰克斯治疗有限公司 2023-01-06 CN disclosed
CN-115368356-A Bicyclic heterocyclic compounds and their therapeutic use 阿斯特克斯治疗有限公司 2022-11-22 CN disclosed
CN-108473464-B Isoindolinone inhibitors of MDM2-P53 interaction with anti-cancer activity 阿斯泰克斯治疗有限公司 2022-08-23 CN disclosed
CN-108290871-B Isoindolinone inhibitors of MDM2-P53 interaction with anti-cancer activity 阿斯泰克斯治疗有限公司 2022-08-23 CN disclosed
CN-109336883-B Bicyclic heterocyclic compounds and their therapeutic use 阿斯特克斯治疗有限公司 2022-06-14 CN disclosed
CN-114206885-A Pyrazolo [3,4-B ] pyrazine SHP2 phosphatase inhibitors 大冢制药株式会社 2022-03-18 CN disclosed
CN-108137546-B Bis-heteroaryl substituted 1, 4-benzodiazepine compounds and their use for the treatment of cancer 詹森药业有限公司 2021-07-27 CN disclosed
CN-108026095-B Novel compounds 詹森药业有限公司 2021-07-27 CN disclosed
CN-111902415-A Pharmaceutical compounds 大冢制药株式会社 2020-11-06 CN disclosed
CN-106459010-B Quinoxaline derivatives as FGFR kinase modulators 阿斯特克斯治疗有限公司 2020-11-03 CN disclosed
EP-1416936-A1 THIOPYRANE-4-ONES AS DNA PROTEIN KINASE INHIBITORS Cancer Research Technology Limited (GB) 2004-05-12 EP disclosed
EP-1397350-A1 ISOQUINOLINONE DERIVATIVES AS PARP INHIBITORS Kudos Pharmaceuticals Limited (GB) 2004-03-17 EP disclosed
WO-2004004720-A1 3-`(HETERO) ARYLMETHOXY ! PYRIDINES AND THEIR ANALOGUES AS P38 MAP KINASE INHIBITORS ASTEX TECHNOLOGY LIMITED (GB) 2004-01-15 WO disclosed
WO-2003093261-A1 PHTHALAZINONE DERIVATIVES KUDOS PHARMACEUTICALS LIMITED (GB) 2003-11-13 WO disclosed
WO-2003070726-A1 PYRANONES USEFUL AS ATM INHIBITORS KUDOS PHARMACEUTICALS LTD (GB) 2003-08-28 WO disclosed
EP-1330442-A1 PHTHALAZINONE DERIVATIVES Kudos Pharmaceuticals Limited (GB) 2003-07-30 EP disclosed
WO-2003024949-A1 DNA-PK INHIBITORS CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2003-03-27 WO disclosed
WO-2003015790-A1 THIOPYRANE-4-ONES AS DNA PROTEIN KINASE INHIBITORS CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2003-02-27 WO disclosed
WO-2002090334-A1 ISOQUINOLINONE DERIVATIVES AS PARP INHIBITORS KUDOS PHARMACEUTICALS LIMITED (GB) 2002-11-14 WO disclosed
WO-2002036576-A1 PHTHALAZINONE DERIVATIVES KUDOS PHARMACEUTICALS LIMITED (GB) 2002-05-10 WO disclosed